Abstract
Objective: The purpose of this study was to observe if luteolin could affect the behavior of cardiac fibroblasts (CFs) on myocardial fibrosis stimulated by angiotensin II (Ang II) and investigate the mechanism involved. Methods: MTT was used to observe the CFs viability and proliferation which was also detected by an EdU staining kit. Cell migration was determined by the transwell chamber. Western blotting was used to examine the protein expression levels of a smooth muscle actin (α -SMA), collagen I and collagen III. The activity of nitric oxide (NO), synthase (NOS), nitrite and cyclic GMP (cGMP) content were measured according to the kits and an enzyme linked immunosorbent assay (ELISA) respectively. Results: The proliferation, migration and expression of α-SMA, collagen I and collagen III in CFs stimulated by Ang II were inhibited by luteolin treatment, and these effects were partly blocked by a combination of treatment with Ang II and NG-nitro-Larginine methyl ester (L-NAME), a non-selective NOS inhibitor, also with 1H-[1,2,4]-oxadiazole -[4,3-a]-quinoxalin-1- one (ODQ), a specific inhibitor of guanylyl cyclase. These effects did not include CFs migration, which showed no apparent difference between Ang II single and together with inhibitors. Luteolin increased the synthesis of total NOS and the content of nitrite and cGMP. Conclusion: These results demonstrate that luteolin is capable of inhibiting the behavior of CFs stimulated by Ang II via up-regulation of NO-cGMP signal pathway.
Keywords: Angiotensin II, cardiac fibroblast, cGMP, fibrosis, luteolin, nitric oxide.
Current Pharmaceutical Biotechnology
Title:Luteolin Antagonizes Angiotensin II-Dependent Proliferation and Collagen Synthesis of Cultured rat Cardiac Fibroblasts
Volume: 16 Issue: 5
Author(s): Tingting Wang, Defeng Pan, Yingying Zhang, Dongye Li, Yanbin Zhang, Tongda Xu, Yuanyuan Luo and Yanfeng Ma
Affiliation:
Keywords: Angiotensin II, cardiac fibroblast, cGMP, fibrosis, luteolin, nitric oxide.
Abstract: Objective: The purpose of this study was to observe if luteolin could affect the behavior of cardiac fibroblasts (CFs) on myocardial fibrosis stimulated by angiotensin II (Ang II) and investigate the mechanism involved. Methods: MTT was used to observe the CFs viability and proliferation which was also detected by an EdU staining kit. Cell migration was determined by the transwell chamber. Western blotting was used to examine the protein expression levels of a smooth muscle actin (α -SMA), collagen I and collagen III. The activity of nitric oxide (NO), synthase (NOS), nitrite and cyclic GMP (cGMP) content were measured according to the kits and an enzyme linked immunosorbent assay (ELISA) respectively. Results: The proliferation, migration and expression of α-SMA, collagen I and collagen III in CFs stimulated by Ang II were inhibited by luteolin treatment, and these effects were partly blocked by a combination of treatment with Ang II and NG-nitro-Larginine methyl ester (L-NAME), a non-selective NOS inhibitor, also with 1H-[1,2,4]-oxadiazole -[4,3-a]-quinoxalin-1- one (ODQ), a specific inhibitor of guanylyl cyclase. These effects did not include CFs migration, which showed no apparent difference between Ang II single and together with inhibitors. Luteolin increased the synthesis of total NOS and the content of nitrite and cGMP. Conclusion: These results demonstrate that luteolin is capable of inhibiting the behavior of CFs stimulated by Ang II via up-regulation of NO-cGMP signal pathway.
Export Options
About this article
Cite this article as:
Wang Tingting, Pan Defeng, Zhang Yingying, Li Dongye, Zhang Yanbin, Xu Tongda, Luo Yuanyuan and Ma Yanfeng, Luteolin Antagonizes Angiotensin II-Dependent Proliferation and Collagen Synthesis of Cultured rat Cardiac Fibroblasts, Current Pharmaceutical Biotechnology 2015; 16 (5) . https://dx.doi.org/10.2174/1389201015666141110142402
DOI https://dx.doi.org/10.2174/1389201015666141110142402 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Selenium in the Prevention and Treatment of Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Thymosin β4 Protein Therapy for Cardiac Repair
Current Pharmaceutical Design Metabolism and Pharmacological Mechanisms of Active Ingredients in <i>Erigeron breviscapus</i>
Current Drug Metabolism Drug-induced Cardiac Mitochondrial Toxicity and Protection: From Doxorubicin to Carvedilol
Current Pharmaceutical Design Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
Current Medicinal Chemistry Chagas Disease: Progress and New Perspectives
Current Medicinal Chemistry Pharmacological Approaches in the Treatment of Atrial Fibrillation
Current Medicinal Chemistry Syncope: Review of Monitoring Modalities
Current Cardiology Reviews Why is the Inhibition of the Renin-Angiotensin System Effective for Preventing Cardiac Events in Patients with Coronary Risk Factors or Coronary Artery Disease?
Current Cardiology Reviews ADAM17 as a Therapeutic Target in Multiple Diseases
Current Pharmaceutical Design Cardiac Applications for Human Pluripotent Stem Cells
Current Pharmaceutical Design Myocardial Revascularization for the Elderly: Current Options, Role of Off-pump Coronary Artery Bypass Grafting and Outcomes
Current Cardiology Reviews Oxidative Biotransformation of Fatty Acids by Cytochromes P450: Predicted Key Structural Elements Orchestrating Substrate Specificity, Regioselectivity and Catalytic Efficiency
Current Drug Metabolism Benzimidazole: A Milestone in the Field of Medicinal Chemistry
Mini-Reviews in Medicinal Chemistry The Role of local Insulin-like Growth Factor-1 Isoforms in the Pathophysiology of Skeletal Muscle
Current Genomics Post-traumatic Stress Disorder in Heart Failure Patients: A Test of the Cardiac Disease-induced PTSD Hypothesis
Current Psychiatry Research and Reviews Decoding the Transcriptional Response to Ischemic Stroke in Obese and Non-obese Mice Brain
Current Neurovascular Research Potential Role of microRNAs in Cardiovascular Disease: Are They up to Their Hype?
Current Cardiology Reviews Postoperative Care of the Transplanted Patient
Current Cardiology Reviews Targeting the Secretory Pathway for Anti-Inflammatory Drug Development
Current Topics in Medicinal Chemistry